Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-05-20T14:33:56.096Z Has data issue: false hasContentIssue false
  • English
  • Français

Cannabis Use in Multiple Sclerosis: Excited Interest

Published online by Cambridge University Press:  02 December 2014

Joep Killestein  and
Chris H. Polman
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 30 , Issue 3 , August 2003 , pp. 181 - 182
Copyright
Copyright © The Canadian Journal of Neurological 2003

References

1. Consroe, P, Musty, R, Rein, J, Tillery, W, Pertwee, R. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 1997; 38(1):44–48.CrossRefGoogle ScholarPubMed
2. Thompson, AJ, Baker, D. Cannabinoids in MS: potentially useful but not just yet! Neurology 2002; 58(9):1323–1324.CrossRefGoogle Scholar
3. Baker, D, Pryce, G, Croxford, JL, et al. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 2000; 404(6773):84–87.CrossRefGoogle Scholar
4. Killestein, J, Hoogervorst, EL, Reif, M, et al. Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 2002; 58(9):1404–1407.CrossRefGoogle ScholarPubMed
5. Wade, DT, Robson, P, House, H, Makela, P, Aram, J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 2003; 17(1):21–29.Google Scholar
6. Page, SA, Verhoef, MJ, Stebbins, RA, Metz, LM, Levy, JC. Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci 2003; 30:201–205.Google Scholar
7. Solowij, N, Stephens, RS, Roffman, RA, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002; 287(9):1123–1131.CrossRefGoogle ScholarPubMed
8. Rao, SM. Neuropsychology of multiple sclerosis. Curr Opin Neurol 1995; 8(3):216–220.Google Scholar
9. van Os, J, Bak, M, Hanssen, M, et al. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002; 156(4):319–327.CrossRefGoogle ScholarPubMed
10. Killestein, J, Hoogervorst, EL, Reif, M, et al. Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis. J Neuroimmunol 2003;137:140–143.Google Scholar